OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Haemothorax reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,867 reports · 84 co-occurring drugs

As of the last recalculation, Haemothorax appears in 2,867 FAERS reports alongside 84 co-occurring drug terms. The strongest observed disproportionality signal is TRANEXAMIC ACID (PRR 38.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tranexamic Acid4638.138.3
Heparin Sodium6032.332.5
Cefazolin Sodium4426.927.0
Norepinephrine Bitartrate5126.226.3
Hydrocortisone Sodium Succinate2922.622.7
Alteplase4622.622.7
Dabigatran Etexilate22322.522.6
Chlorhexidine Gluconate2721.621.7
Dabigatran Etexilate Mesylate19721.121.1
Fondaparinux Sodium2018.118.1
Rocuronium Bromide2616.216.2
Ibrutinib15514.714.7
Norepinephrine2114.414.4
Basiliximab2314.314.3
Rivaroxaban36014.214.2
Cefazolin1713.613.6
Amphotericin B2313.413.4
Acalabrutinib2112.712.7
Apixaban10611.911.9
Febuxostat Tablets 40 Mg1510.810.8
Febuxostat Tablets 80 Mg1510.810.8
Dornase Alfa259.39.3
Clopidogrel Bisulfate1188.78.7
Vancomycin Hydrochloride748.38.3
Piperacillin Sodium And Tazobactam Sodium228.28.2
Propofol408.08.1
Enoxaparin Sodium628.08.0
Dronedarone117.97.9
Warfarin1307.77.7
Captopril107.67.6
Warfarin Sodium477.57.5
Voriconazole Injection217.17.1
Febuxostat167.07.0
Voriconazole286.76.8
Amiodarone Hydrochloride106.56.5
Metolazone106.56.5
Insulin Glulisine96.46.4
Dalteparin Sodium96.26.2
Vancomycin486.16.1
Clopidogrel1596.16.1
Digoxin565.85.8
Torsemide265.75.7
Prasugrel Hydrochloride85.75.7
Gefitinib75.65.6
Dasatinib285.55.5
Pemetrexed165.45.4
Cefepime Hydrochloride125.45.4
Pemetrexed Disodium285.45.4
Valganciclovir Hydrochloride Powder,95.45.4
Everolimus Tablets125.25.2
Bisoprolol Fumarate945.25.2
Piperacillin And Tazobactam95.15.1
Gentamicin95.05.0
Sorafenib144.94.9
Terazosin Hydrochloride64.94.9
Tobramycin Solution84.84.8
Prochlorperazine Maleate64.74.7
Emicizumab84.74.7
Tobramycin Sulfate84.74.7
Mycophenilic Acid134.64.6
Meropenem204.54.6
Tacrolimus Ointment 0.1%754.54.5
Tacrolimus Extended-Release Capsules754.54.5
Sotalol Hydrochloride104.44.4
Erlotinib Hydrochloride74.14.1
Tolvaptan84.04.0
Epoprostenol73.93.9
Ticagrelor163.73.7
Obinutuzumab83.53.5
Romiplostim73.43.4
Fesoterodine Fumarate53.43.4
Sunitinib Malate173.23.2
Entecavir53.13.1
Tobramycin103.03.0
Erlotinib43.03.0
Atezolizumab152.82.8
Pazopanib Hydrochloride102.72.7
Iohexol32.62.6
Travoprost32.52.5
Azacitidine102.52.5
Ethyl Alcohol92.42.4
Remdesivir42.22.2
Tapentadol Hydrochloride71.51.5
Osimertinib61.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.